Company:ProMetic Life Sciences
 | |
| Industry | Biopharmaceutical Pharmaceutical |
|---|---|
| Founded | October 14, 1994 |
| Headquarters | 440 Boul. Armand-Frappier Suite 300, Laval, Québec , |
| Website | prometic |
Prometic Life Sciences Inc. is a Canada publicly traded biopharmaceutical company.
History
Prometic was founded in 1988, as a commercial spinoff of research at the University of Cambridge on affinity chromatography.[1] Its founder was the current President and CEO, Pierre Laurin, whose research formed the basis for the company's products.[1] On May 19, 1998,the Corporation went public through a listing on the Toronto Stock Exchange.
In August 2016, the company announced the acquisition of Telesta Therapeutics.[2]
Business
Most of the company's products are based on its affinity chromatography process. One use of this process is the purification of drugs, reducing impurities and thus side effects.[1] A second use is removing pathogens from human blood; in 2002, ProMetic formed a joint venture with the American Red Cross to remove pathogens and viruses from collected blood.[3] A third application is to extract and purify therapeutic proteins from human plasma, which are then used in the creation of therapeutics and orphan drugs.
Prometic has two business segments: the protein technologies segment and the small-molecule therapeutics segment.
The small-molecule therapeutics segment produces products for sufferers of fibrosis, cancer and autoimmune diseases. The company most prominent product is PBI-4050, an anti-fibrosis product. [4]
Headquartered in Laval, Quebec, Prometic has:
- Research and development facilities in the UK, the US and Canada
- Manufacturing facilities in the UK and Canada[5]
It also conducts business development activities in the US, Europe and Asia. As of 2015, it has approximately 250 employees.
References
- ↑ 1.0 1.1 1.2 "Most Innovative CEO of the Year: Pierre Laurin, Prometic" (in en-US). Canadian Business - Your Source For Business News. 2015-10-19. http://www.canadianbusiness.com/leadership/ceo-of-the-year/most-innovative-ceo-pierre-laurin-prometic-life-sciences/.
- ↑ "ProMetic to Acquire Telesta Therapeutics - GEN". http://www.genengnews.com/gen-news-highlights/prometic-to-acquire-telesta-therapeutics/81253125/.
- ↑ "ProMetic to team with Red Cross". The Globe and Mail. 2002-04-22. https://www.theglobeandmail.com/report-on-business/prometic-to-team-with-red-cross/article4133590/.
- ↑ "Three top stock picks from Selective Asset’s Robert McWhirter". The Globe and Mail. 2014-08-29. https://www.theglobeandmail.com/globe-investor/investment-ideas/three-top-stock-picks-from-selective-assets-robert-mcwhirter/article20285042/.
- ↑ "Today's Stock Market News and Analysis from Nasdaq.com". http://www.nasdaq.com/press-release/emergent-biosolutions-signs-longterm-manufacturing-agreement-with-prometic-life-sciences-20150519-00232.
 |
